ClinicalTrials.Veeva

Menu

Metabolite Biomarkers Related to Acute Rejection in Kidney Transplantation

Seoul National University logo

Seoul National University

Status

Unknown

Conditions

Kidney Transplantation
Rejection Acute Renal

Study type

Observational

Funder types

Other

Identifiers

NCT03134625
1606-069-771

Details and patient eligibility

About

The development of acute rejection can only be considered in cases with increasing serum creatinine in patients with kidney transplantation. However, the serum creatinine itself is not specific but also accurate for detection of acute rejection. So The specific biomarker is required for acute rejection of kidney transplant. In this study, the investigators will enroll 200 consecutive kidney transplant patients in Seoul National University Hospital and follow up. Serial collection of urine and serum will be done. Acute rejection specific urine metabolite will be found by LC MS/MS.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Kidney transplant patients in Seoul National University Hospital
  • Patients with triple maintenance immunosuppression including Tacrolimus, mycophenolate and steroid

Exclusion criteria

  • History of other organ transplantation
  • ABOi and/or crossmatch(+) transplantation

Trial contacts and locations

1

Loading...

Central trial contact

Jongwon Ha, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems